Cresset Asset Management, LLC Eli Lilly & CO Transaction History

Cresset Asset Management, LLC

$21.3 Billion
Q3 2025

A detailed history of Cresset Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cresset Asset Management, LLC holds 66,054 shares of LLY stock, worth $65.3 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

66,054

Previous 68,718 3.88%

Holding current value

$65.3 Million

Previous $53.6 Million 5.91%

% of portfolio

0.24%

Previous 0.27%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$625.65 - $812.69 $1.67 Million - $2.17 Million	-2,664 Reduced 3.88%	66,054 $50.4 Million
Q2 2025 Aug 13, 2025	BUY	$713.71 - $898.95 $738,689 - $930,413	1,035 Added 1.53%	68,718 $53.6 Million
Q1 2025 May 13, 2025	SELL	$725.72 - $929.72 $8.21 Million - $10.5 Million	-11,307 Reduced 14.31%	67,683 $55.9 Million
Q4 2024 Feb 14, 2025	SELL	$727.2 - $932.06 $39.4 Million - $50.5 Million	-54,144 Reduced 40.67%	78,990 $61 Million
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $1.72 Million - $2.14 Million	2,231 Added 1.7%	133,134 $118 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $21.8 Million - $27.3 Million	30,044 Added 29.79%	130,903 $119 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $5.03 Million - $6.73 Million	8,492 Added 9.19%	100,859 $78.5 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $3.2 Million - $3.78 Million	6,101 Added 7.07%	92,367 $53.8 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $117,369 - $161,811	-270 Reduced 0.31%	86,266 $46.3 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $18.1 Million - $24.2 Million	51,504 Added 147.02%	86,536 $40.6 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $29.7 Million - $34.9 Million	-95,564 Reduced 73.18%	35,032 $12 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $3,215 - $3,746	-10 Reduced 0.01%	130,596 $47.8 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $1.79 Million - $2.04 Million	6,040 Added 4.85%	130,606 $42.2 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $701,563 - $823,738	-2,517 Reduced 1.98%	124,566 $39.9 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $1.46 Million - $1.82 Million	-6,224 Reduced 4.67%	127,083 $36.4 Million
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $1.65 Million - $2.05 Million	7,332 Added 5.82%	133,307 $36.8 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $1.68 Million - $2.07 Million	-7,592 Reduced 5.68%	125,975 $29.1 Million
Q2 2021 Aug 10, 2021	BUY	$180.55 - $233.54 $1.32 Million - $1.71 Million	7,315 Added 5.79%	133,567 $30.7 Million
Q1 2021 May 12, 2021	BUY	$164.32 - $212.72 $624,251 - $808,123	3,799 Added 3.1%	126,252 $23.6 Million
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $594,767 - $787,020	-4,559 Reduced 3.59%	122,453 $20.7 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $34,361 - $39,745	235 Added 0.19%	127,012 $18.8 Million
Q2 2020 Aug 04, 2020	BUY	$136.42 - $164.18 $1.63 Million - $1.96 Million	11,946 Added 10.4%	126,777 $20.8 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $585,964 - $725,256	4,922 Added 4.48%	114,831 $15.9 Million
Q4 2019 Feb 10, 2020	BUY	$106.92 - $132.43 $120,605 - $149,381	1,128 Added 1.04%	109,909 $14.4 Million
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $112,449 - $122,316	1,053 Added 0.98%	108,781 $12.2 Million
Q2 2019 Aug 12, 2019	SELL	$110.79 - $129.32 $1.09 Million - $1.27 Million	-9,814 Reduced 8.35%	107,728 $11.9 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $3.47 Million - $4.09 Million	31,204 Added 36.14%	117,542 $15.3 Million
Q4 2018 May 21, 2019	BUY	$105.9 - $118.64 $9.14 Million - $10.2 Million	86,338 New	86,338 $9.99 Million

Others Institutions Holding LLY

# of Institutions

4,496

Shares Held

767M

Call Options Held

16.7M

Put Options Held

12.6M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $939B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.

Account

Cresset Asset Management, LLC Eli Lilly & CO Transaction History